NASDAQ · Medical - Healthcare Information Services

SOPH (SOPH) Stock

$5.55 -0.36% NASDAQ: SOPH Healthcare

Valuation

MetricValue
Price$5.55
Market Cap$381.50M
P/E Ratio-9.02
P/B Ratio7.94
P/S Ratio4.45
EPS (TTM)$-0.56
52-Week High$6.70
52-Week Low$2.81
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-123.28%
ROA-29.71%
ROCE-151.06%
Gross Margin67.28%
Operating Margin-88.39%
Net Margin-99.70%
Debt/Equity1.37
Current Ratio1.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$40.0M$48.0M$62.0M$65.0M$77.0M
Operating Profit$-71.0M$-88.0M$-75.0M$-67.0M$-71.0M
Net Profit$-74.0M$-87.0M$-79.0M$-62.0M$-79.0M
EPS$-1.33$-1.36$-1.22$-0.95$-1.17
Op Margin-176.7%-184.7%-120.0%-102.1%-91.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$320.0M$244.0M$206.0M$155.0M$163.0M
Total Liabilities$45.0M$44.0M$55.0M$59.0M$116.0M
Cash$193.0M$161.0M$123.0M$80.0M$70.0M
Borrowings$13.0M$17.0M$19.0M$30.0M$63.0M

Latest News

Sophia Genetics Insider Sold Shares Worth $286,099, According to a Recent SEC Filing MT Newswires · Jul 22, 2026 SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 PR Newswire · Jul 21, 2026 HC Wainwright Initiates SOPHiA GENETICS at Buy With $12 Price Target MT Newswires · Jul 20, 2026 Sophia Genetics Insider Sold Shares Worth $506,690, According to a Recent SEC Filing MT Newswires · Jul 1, 2026 Sophia Genetics Insider Sold Shares Worth $298,155, According to a Recent SEC Filing MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-58.0M$-70.0M$-49.0M$-43.0M$-38.0M
Investing Cash Flow$-64.0M$32.0M$-1.0M$-16.0M$-11.0M
Financing Cash Flow$11.0M$1.0M$0$0$0
Net Cash Flow$118.0M$-32.0M$-38.0M$-43.0M$-10.0M
Free Cash Flow$-65.0M$-80.0M$-58.0M$-51.0M$-39.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-4.94
FCF Yield-12.58%
Quick Ratio1.90
Interest Coverage-14.20
Return 1Y67.59%
Return 3Y53.55%
Return 5Y—

Ownership

Insiders Held7.08%
Institutions Held48.04%
Institutions Float Held51.70%
Institutional HolderSharesReport Date
Generation Investment Management LLP6,789,5602026-03-31
Akre Capital Management, LLC3,719,1402026-03-31
Banque Pictet & Cie SA2,208,2802026-03-31
Soleus Capital Management, L.P.1,850,0002026-03-31
Royce & Associates LP1,816,3122026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACIU $2.31 +0.22% -4.04 $234.59M 0.00%
AGL $99.07 +0.11% -3.60 $1.65B 0.00%
ANRO $28.67 +0.70% -6.29 $1.01B 0.00%
CLLSCellectis S.A. $2.81 -2.26% -4.14 $282.17M 0.00%
DH $0.67 -1.38% 4.29 $71.08M 0.00%

About SOPH

SOPH is led by CEO Jurgi Camblong, employs 423 people, headquartered in CH, publicly traded since 2021.

SOPH stock trades at $5.55 with a market capitalization of $381.50M. The stock is valued at a price-to-earnings (P/E) ratio of -9.02, price-to-book of 7.94, price-to-sales of 4.45. Over the past 52 weeks the stock has ranged between $2.81 and $6.70, and currently trades 17.2% below its 52-week high.

On profitability, SOPH generates a return on equity (ROE) of -123.28%, return on capital employed of -151.06%, an operating margin of -88.39%, a net profit margin of -99.70%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides